Abstract
Non-progressive retinal lesions, observed in patients known to carry the gene for retinoblastoma, have in the past been called "spontaneous regression" of retinoblastoma. This term suggests shrinkage of a malignant growth, perhaps in response to some host defence mechanism. On the basis of observations on 30 patients, we propose that the term "retinoma" would be less presumptive and more suitable. Retinoma is clinically defined as a translucent, grey, elevated mass extending into the vitreous from the retina, frequently associated with calcified foci and pigment-epithelium hyperplasia. The diagnosis of retinoma strongly suggests the presence of the retinoblastoma gene, necessitating genetic counselling and frequent observation of the retinas in the individual and his offspring. We suggest that the same mutations can cause either retinoma or retinoblastoma: benign hyperplastic nodules or retinoma when the mutations occur in relatively mature retinoblasts, and malignant retinoblastoma when the same mutations arise in immature retinoblasts.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Gallie, B., Ellsworth, R., Abramson, D. et al. Retinoma: Spontaneous regression of retinoblastoma or benign manifestation of the mutation?. Br J Cancer 45, 513–521 (1982). https://doi.org/10.1038/bjc.1982.87
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.87
This article is cited by
-
Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact
Eye (2023)
-
Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma
Cell Death & Disease (2021)
-
The value of “en toto” globe submission in the assessment of high-risk retinoblastoma cases and staging
International Ophthalmology (2017)
-
Retinoblastom und Retinozytom (Retinom)
Der Pathologe (2017)